TVRD financials
Tvardi Therapeutics (TVRD) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
TVRD income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | – | – | -$26.75M | -$18.21M | -3.26 |
| 2024 | $7.14M | $6.52M | -$28.11M | -$29.40M | -11.42 |
| 2023 | $20.97M | $14.79M | -$121.50M | -$118.51M | -78.78 |
| 2022 | $41.87M | $34.60M | -$87.53M | -$85.47M | -57.36 |
| 2021 | $23.03M | – | -$89.08M | -$88.44M | -62.64 |
| 2020 | $135.08M | – | $5.38M | $8.41M | 6.48 |